ESSA Pharma Inc.
General ticker "EPIX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $75.7M (TTM average)
ESSA Pharma Inc. does not follow the US Stock Market performance with the rate: -17.9%.
Estimated limits based on current volatility of 3.7%: low 0.20$, high 0.21$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-08-19, amount 1.69$ (Y839.96%)
- Total employees count: 35 (-30.0%) as of 2024
- Top business risk factors: Intellectual property risks, Profitability concerns, Market volatility, Pandemic risks, Shareholder activism
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [3.94$, 8.87$]
- 2025-09-30 to 2026-09-30 estimated range: [2.80$, 6.68$]
Financial Metrics affecting the EPIX estimates:
- Negative: with PPE of -9.9 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -8.12 <= 0.85
- Positive: Shareholder equity ratio, % of 97.26 > 62.86
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -24.83 <= 2.35
Short-term EPIX quotes
Long-term EPIX plot with estimates
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $35.34MM | $32.13MM | $34.42MM |
| Operating Income | $-35.34MM | $-32.13MM | $-34.42MM |
| Non-Operating Income | $0.13MM | $5.55MM | $5.88MM |
| Interest Expense | $0.01MM | $0.01MM | $0.00MM |
| R&D Expense | $24.41MM | $21.32MM | $21.21MM |
| Income(Loss) | $-35.22MM | $-26.58MM | $-28.54MM |
| Taxes | $-0.11MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-35.10MM | $-26.58MM | $-28.54MM |
| Stockholders Equity | $167.12MM | $145.63MM | $124.61MM |
| Inventory | $110.61MM | $0.00MM | $0.00MM |
| Assets | $169.51MM | $149.12MM | $128.11MM |
| Operating Cash Flow | $-28.70MM | $-19.78MM | $-22.72MM |
| Investing Cash Flow | $-52.35MM | $-3.53MM | $91.79MM |
| Financing Cash Flow | $0.25MM | $-0.07MM | $0.93MM |
| Earnings Per Share** | $-0.80 | $-0.60 | $-0.64 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.